Simplex Trading
NGNE icon

Simplex Trading’s Neurogene NGNE Stock Holding History

Simplex Trading’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.79K Buy
89
+27
+44% +$523 ﹤0.01% 8410
2025
Q4 		$1.28K Sell
62
-1,172
-95% -$29.2K ﹤0.01% 7968
2025
Q3 		$21K Sell
1,234
-477
-28% -$9.58K ﹤0.01% 7291
2025
Q2 		$25K Buy
1,711
+866
+102% +$13.6K ﹤0.01% 6579
2025
Q1 		$9K Buy
+845
New +$14.7K ﹤0.01% 7182
2022
Q3 		– Sell
-9
Closed -$184 – 10556
2022
Q2 		$0 Sell
9
-2,356
-100% -$57.5K ﹤0.01% 10688
2022
Q1 		$88K Buy
2,365
+2,184
+1,207% +$127K ﹤0.01% 6330
2021
Q4 		$17K Buy
+181
New +$22.1K ﹤0.01% 8554
2021
Q2 		– Sell
-5
Closed -$1.11K – 10471
2021
Q1 		$1K Sell
5
-25
-83% -$6.39K ﹤0.01% 8565
2020
Q4 		$8K Sell
30
-16
-35% -$3.91K ﹤0.01% 7536
2020
Q3 		$10K Buy
+46
New +$11.1K ﹤0.01% 6787
2020
Q2 		– Sell
-42
Closed -$10.9K – 8092
2020
Q1 		$9K Buy
+42
New +$8.64K ﹤0.01% 6542
2019
Q4 		– Sell
-54
Closed -$5.38K – 7734
2019
Q3 		$3K Buy
+54
New +$3.29K ﹤0.01% 6811
2018
Q4 		– Sell
-707
Closed -$34.4K – 7545
2018
Q3 		$41K Buy
+707
New +$41.7K ﹤0.01% 5348
2018
Q2 		– Sell
-343
Closed -$89.4K – 7719
2018
Q1 		$96K Buy
343
+278
+428% +$76.8K ﹤0.01% 1840
2017
Q4 		$15K Buy
65
+60
+1,200% +$14.1K ﹤0.01% 3572
2017
Q3 		$1K Buy
+5
New +$1.44K ﹤0.01% 5508
2017
Q2 		– Sell
-109
Closed -$31.2K – 6553
2017
Q1 		$36K Buy
109
+42
+63% +$14.8K ﹤0.01% 2667
2016
Q4 		$22K Buy
+67
New +$18K ﹤0.01% 2957

Other funds holding NGNE

SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $437M AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Simplex Trading's NGNE Position: Q1 2026 in Review

Simplex Trading increased its Neurogene (NGNE) stake by 44% in Q1 2026, buying an estimated $523 and bringing the position to 89 shares worth $1.79K. The position accounts for ﹤0.01% of the portfolio, ranked #8410.

Simplex Trading first reported a position in NGNE in Q4 2016 and has held it in 19 quarters since. The position peaked at $96K in Q1 2018. 96 funds tracked by Wall St. Rank hold NGNE as of Q1 2026.

  • Simplex Trading held 89 shares of Neurogene worth $1.79K as of Q1 2026.
  • Simplex Trading bought 27 Neurogene shares in Q1 2026, an estimated $523.
  • Neurogene made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #8410 holding.
  • Simplex Trading first reported a position in Neurogene in Q4 2016 and has held it in 19 quarters since.
  • Simplex Trading's Neurogene position peaked at $96K in Q1 2018.
  • 96 funds tracked by Wall St. Rank held Neurogene as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.